Showing results (151-160 of 161) with videos related to
Sort By:
Pageof 17
Journal of the American College of Cardiology|January 30, 2007
Impact of stable versus unstable coronary artery disease on 1-year outcome in elective patients undergoing multivessel revascularization with sirolimus-eluting stents: a subanalysis of the ARTS II trialMarco Valgimigli, Keith Dawkins, Carlos Macaya, et al.European Journal of Epidemiology|September 20, 2005
Phenotypic subtypes in attention deficit hyperactivity disorder in an isolated populationEsther A Croes, Rachid El Galta, Jeanine J Houwing-Duistermaat, et al.Acta Oncologica (Stockholm, Sweden)|March 7, 2020
Secondary analyses of the randomized phase III Stop&Go study: efficacy of second-line intermittent versus continuous chemotherapy in HER2-negative advanced breast cancerAnouk K M Claessens, Frans L G Erdkamp, Marta Lopez-Yurda, et al.The British Journal of Dermatology|March 26, 2003
Beneficial effects of fumarate therapy in psoriasis vulgaris patients coincide with downregulation of type 1 cytokinesN H R Litjens, P H Nibbering, A J Barrois, et al.The American Journal of Cardiology|February 24, 2007
Two-year serial coronary angiographic and intravascular ultrasound analysis of in-stent angiographic late lumen loss and ultrasonic neointimal volume from the TAXUS II trialKeiichi Tsuchida, Patrick W Serruys, Nico Bruining, et al.Clinical Oral Investigations|November 22, 2016
Growth and prevalence of feeding difficulties in children with Robin sequence: a retrospective cohort studyEmma C Paes, Iris A C de Vries, Wouter M Penris, et al.Breast (Edinburgh, Scotland)|February 20, 2025
Side-effects in women treated with adjuvant endocrine therapy for breast cancerL M Rademaker, R Gal, A M May, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2007
Phase I pharmacokinetic and pharmacodynamic study of the oral protein kinase C beta-inhibitor enzastaurin in combination with gemcitabine and cisplatin in patients with advanced cancerJeany M Rademaker-Lakhai, Laurens V Beerepoot, Niven Mehra, et al.Human Genetics|December 22, 2005
Evidence for novel loci for late-onset Parkinson's disease in a genetic isolate from the NetherlandsAida M Bertoli-Avella, Marieke C J Dekker, Yurii S Aulchenko, et al.Breast Cancer Research and Treatment|August 20, 2018
Intermittent versus continuous first-line treatment for HER2-negative metastatic breast cancer: the Stop & Go study of the Dutch Breast Cancer Research Group (BOOG)Anouk K M Claessens, Monique E M M Bos, Marta Lopez-Yurda, et al.Pageof 17